RE:RE:RE:GBM.....get it done ! How much would this dude have paid???? When his son was diagnosed with brain cancer, one billionaire in 2012 bought a biotech that was thought to have a promising molecule against brain cancer. The stock was trading @2$. It ended up that the molecule didn't deliver on brain cancer but was successful in cardiology. He bought in @2$. The biotech was then later on acquired for 21B$ (262$/share).
https://www.ft.com/content/c2f2fdba-c405-11e4-a02e-00144feab7de
______________
skier59 - (8/2/2022 12:23:09 PM)
RE:RE:GBM.....get it done ! How much would this dude have paid????
I'll bet he would of financed the whole Phase 1 trial if he could of been 1 of the few lucky ones to participate in the future clinical study.